Raymond James & Associates’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.34M | Sell |
|
|||||
|
2024
Q2 | $1.03M | Sell |
|
|||||
|
2024
Q1 | $1M | Buy |
|
|||||
|
2023
Q4 | $981K | Sell |
|
|||||
|
2023
Q3 | $765K | Buy |
|
|||||
|
2023
Q2 | $500K | Hold |
|
|||||
|
2023
Q1 | $224K | Hold |
|
|||||
|
2022
Q4 | $321K | Hold |
|
|||||
|
2022
Q3 | $326K | Sell |
|
|||||
|
2022
Q2 | $528K | Sell |
|
|||||
|
2022
Q1 | $700K | Sell |
|
|||||
|
2021
Q4 | $826K | Sell |
|
|||||
|
2021
Q3 | $935K | Buy |
|
|||||
|
2021
Q2 | $886K | Buy |
|
|||||
|
2021
Q1 | $1.14M | Sell |
|
|||||
|
2020
Q4 | $795K | Sell |
|
|||||
|
2020
Q3 | $676K | Buy |
|
|||||
|
2020
Q2 | $799K | Buy |
|
|||||
|
2020
Q1 | $583K | Buy |
|
|||||
|
2019
Q4 | $629K | Buy |
|
|||||
|
2019
Q3 | $283K | Buy |
|
|||||
|
2019
Q2 | $313K | Buy |
|
|||||
|
2019
Q1 | $537K | Sell |
|
|||||
|
2018
Q4 | $635K | Sell |
|
|||||
|
2018
Q3 | $1.3M | Buy |
|
|||||
|
2018
Q2 | $721K | Buy |
|